The docking results revealed that CD-437, 3-Cl-AHPC, Trametinib, BI-2536, and GSK461364 had high binding affinities to CENPA (S3 Table), suggesting that these drugs are likely to directly target CENPA in cancer cells. The gene discussed is CENPA; the disease is cancer.